Cargando...
Treatment of homozygous sickle cell disease with pentoxifylline.
This case report describes the sustained symptomatic and hematologic improvement in a 21-year-old woman with homozygous sickle cell (ss) disease during treatment with pentoxifylline, 400 mg three times daily after meals. Pain crises decreased from six to zero per year, hemoglobin level rose from 8.4...
Guardado en:
Autor principal: | |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
National Medical Association
1999
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2608440/ https://ncbi.nlm.nih.gov/pubmed/12656436 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|